DVADaVita
Is it growing?
Neither accelerating nor breaking down: nothing decisive, though earnings up +20% year on year.
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +4% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 15.2% now against 15.8% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is DVA growing?
DaVita has grown revenue 6.1% a year over three years and 3.9% a year over five, with earnings per share compounding at 34%.
Revenue growth, 3-year annual rate · Medical Care Facilities median +8.2% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +3.9%
Revenue growth, 5-year rate · +6.1% over three · growth has picked up over the last three years
- Earnings per share, 3-year rate
- +34%
Earnings per share, 3-year rate · revenue +6.1% · earnings outgrew revenue: margins or the share count worked for shareholders
- Years of annual history on file
- 19
Years of annual history on file · FY2007 to FY2025, as filed
Details›
- Revenue FY2021
- $11.6B
- Revenue FY2022
- $11.6B
- Revenue FY2023
- $12.1B
- Revenue FY2024
- $12.8B
- Revenue FY2025
- $13.6B
Annual income statements as filed with the SEC.
Medical Care Facilities
The closest names by size in the same industry